240 related articles for article (PubMed ID: 16520821)
21. Targeted delivery systems of small interfering RNA by systemic administration.
Kawakami S; Hashida M
Drug Metab Pharmacokinet; 2007 Jun; 22(3):142-51. PubMed ID: 17603214
[TBL] [Abstract][Full Text] [Related]
22. The therapeutic potential of siRNA in gene therapy of neurodegenerative disorders.
Koutsilieri E; Rethwilm A; Scheller C
J Neural Transm Suppl; 2007; (72):43-9. PubMed ID: 17982877
[TBL] [Abstract][Full Text] [Related]
23. [SiRNA technology, the gene therapy of the future?].
Rácz Z; Hamar P
Orv Hetil; 2008 Jan; 149(4):153-9. PubMed ID: 18201957
[TBL] [Abstract][Full Text] [Related]
24. Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs.
Dykxhoorn DM; Lieberman J
Annu Rev Biomed Eng; 2006; 8():377-402. PubMed ID: 16834561
[TBL] [Abstract][Full Text] [Related]
25. Personalized gene silencing therapeutics for Huntington disease.
Kay C; Skotte NH; Southwell AL; Hayden MR
Clin Genet; 2014 Jul; 86(1):29-36. PubMed ID: 24646433
[TBL] [Abstract][Full Text] [Related]
26. Small interfering RNA-based molecular therapy of cancers.
Guo W; Chen W; Yu W; Huang W; Deng W
Chin J Cancer; 2013 Sep; 32(9):488-93. PubMed ID: 23327796
[TBL] [Abstract][Full Text] [Related]
27. Toward silencing the burden of malaria: progress and prospects for RNAi-based approaches.
Brown AE; Catteruccia F
Biotechniques; 2006 Apr; Suppl():38-44. PubMed ID: 16629386
[TBL] [Abstract][Full Text] [Related]
28. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
[TBL] [Abstract][Full Text] [Related]
29. Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications.
Huang C; Li M; Chen C; Yao Q
Expert Opin Ther Targets; 2008 May; 12(5):637-45. PubMed ID: 18410245
[TBL] [Abstract][Full Text] [Related]
30. Journey of siRNA: Clinical Developments and Targeted Delivery.
Nikam RR; Gore KR
Nucleic Acid Ther; 2018 Aug; 28(4):209-224. PubMed ID: 29584585
[TBL] [Abstract][Full Text] [Related]
31. Competition potency of siRNA is specified by the 5'-half sequence of the guide strand.
Yoo JW; Kim S; Lee DK
Biochem Biophys Res Commun; 2008 Feb; 367(1):78-83. PubMed ID: 18164261
[TBL] [Abstract][Full Text] [Related]
32. The impact of target site accessibility on the design of effective siRNAs.
Tafer H; Ameres SL; Obernosterer G; Gebeshuber CA; Schroeder R; Martinez J; Hofacker IL
Nat Biotechnol; 2008 May; 26(5):578-83. PubMed ID: 18438400
[TBL] [Abstract][Full Text] [Related]
33. Nucleic Acid Therapeutics in Huntington's Disease.
Singh K; Roy I
Recent Pat Biotechnol; 2019; 13(3):187-206. PubMed ID: 30747088
[TBL] [Abstract][Full Text] [Related]
34. siRNA: novel therapeutics from functional genomics.
Joshi BH; Pachchigar KP
Biotechnol Genet Eng Rev; 2014 Oct; 30(1-2):1-30. PubMed ID: 25023460
[TBL] [Abstract][Full Text] [Related]
35. RNAi as a treatment for HIV-1 infection.
Rossi JJ
Biotechniques; 2006 Apr; Suppl():25-9. PubMed ID: 16629384
[TBL] [Abstract][Full Text] [Related]
36. Gene silencing of HIV-1 by RNA interference.
Takaku H
Antivir Chem Chemother; 2004 Mar; 15(2):57-65. PubMed ID: 15185724
[TBL] [Abstract][Full Text] [Related]
37. [Establish a screening system for selection of mRNA target sites for HBsAg to construct siRNA with shRNA].
Yang ZG; Chen Z; Xu N; Ni Q; Pan XC; Jin HY; Li MW
Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):515-8. PubMed ID: 15387899
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic potential of RNAi in metabolic diseases.
Rondinone CM
Biotechniques; 2006 Apr; Suppl():31-6. PubMed ID: 16629385
[TBL] [Abstract][Full Text] [Related]
39. Rational design of therapeutic siRNAs: minimizing off-targeting potential to improve the safety of RNAi therapy for Huntington's disease.
Boudreau RL; Spengler RM; Davidson BL
Mol Ther; 2011 Dec; 19(12):2169-77. PubMed ID: 21952166
[TBL] [Abstract][Full Text] [Related]
40. RNA interference as a potential tool in the treatment of leukaemia.
Borkhardt A; Heidenreich O
Expert Opin Biol Ther; 2004 Dec; 4(12):1921-9. PubMed ID: 15571454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
